Successful early detection strategies will require identification of clinically relevant precursor lesions that can be targets for screening and treatment ... oesophagitis 0.8 (0.2–3.2), basal cell ...

1 Esophageal Diseases Center ... reflux oesophagitis in humans began with T lymphocyte-predominant inflammation, and with basal cell and papillary hyperplasia developing before loss of surface cells.

Association with obesity has also been proposed for other cancer types, as thyroid, kidney, esophagus, gastric cardia ... and energy expenditure [basal metabolic rate plus mechanical energy by muscle ...

The new treatment option for basal cell carcinoma can not only simplify surgery, but also help to avoid disfiguring operations and functional limitations." Julia Ressler, First Author, Department ...

Objective: Intralesional injections of interferon have been reported to provide successful results in the treatment of basal cell carcinoma. However, there are only a few reports describing the ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

Staying in the New England Journal of Medicine then, let's turn to this issue of perioperative chemotherapy or preoperative chemoradiotherapy for the treatment of locally advanced esophageal ...

President Trump signed an executive order on Tuesday that would restrict access to treatments, including puberty blockers and hormones, for transgender children and teens. Trump is directing ...